Loading viewer...
investor_presentation
Format: PDF investor_presentation
Earnings Release Call Third Quarter 2021 Tuesday, November 2, 2021
Earnings Release Call
Tuesday, November 2, 2021On the Call Today
President and CEOFay West
Forward-Looking Statements &
Our remarks this morning and our answers to questions may contain forward-
looking statements regarding the company’s expectations of future performance.
Such statements are subject to risks and uncertainties, and our actual results may
differ materially from those contained in the statements. These risks and
uncertainties are described in today’s news release and the documents we file with
the Securities and Exchange Commission. We encourage you to review those
documents, particularly our Safe Harbor statement, for a description of the risks
and uncertainties that may affect our results.
Additionally, on this conference call we will discuss non-GAAP measures that
include or exclude certain items. Our 2021 third-quarter earnings release includes
the comparable GAAP measures and a reconciliation of these non-GAAP
measures to our GAAP results.
Financial Results Conference Call
4Third Quarter 2021
Results reflect a return to pre-pandemic demand across the majority of our
geographic markets and verticals
Financial performance continued to be impacted by the unexpected and
prolonged global supply disruptions, inflation and labor constraints
Expect that these macro headwinds will continue well into 2022
Record level of order backlog – 3 to 5 times historical average
Varies across product category and region
Plants remain open and are operating
5Actions to address
macro challenges Prioritize local-for-local and region-for-
region manufacturing and sourcing.
Adding production capability to our China
Preview truncated — download the full document for the complete content.
investor_presentation
27 Pages
Tennant Company Investor Presentation — April 2019
investor_presentationinvestor_presentation
16 Pages
investor_presentation
26 Pages
Brainstorm Cell Therapeutics